Category: Business/Financial News
Natick medical device leviathan’s Taxus Liberte drug-eluting stent approved for sale in Japan.
Boston Scientific Corp.'s Taxus Liberte drug-eluting stent was given regulatory approvals in Japan, clearing the way for its appearance on the Japanese market.
The Natick medical device leviathan said March 3 that its paclitaxel-eluting coronary stent system was approved Jan. 28 by Japan’s Ministry of Health, Labor and Welfare. Reimbursement was granted March 2 by the country’s National Health Insurance System.
About 1,300 medical centers perform cardiac catheterizations in Japan, implanting an estimated 200,000 coronary stents annually, according to Boston Scientific.
Billerica scientific instrument maker beats analyst’s fourth-quarter expectations, but tighter profit margins prove to be costly.
The good news for Bruker BioScience Corp. is that it plans to aggressively invest in R&D efforts and expand into new markets. The bad news is that the company must cut jobs, freeze salaries and cut back on discretionary spending to do it.
“We were not satisfied with our operating margin trends in 2008,” CEO Frank Laukien said in a March 3 conference call with investors. “Our focus in 2009 is on cost-cutting and gross margin improvement, but we also intend to take advantage of new opportunities in the current market using our industry-leading products to continue to gain market share.”
Springfield consulting firm acquires Pennsylvania company’s compliance services arm.
Court Square acquired QA Edge’s computer validation business for an undisclosed amount.
Springfield-based Court Square, which provides clinical, regulatory, manufacturing and quality assurance services to life science companies, said the deal augments its QC consulting practice and is part of its planned expansion on the East Coast.
The QA Edge business is based in Garnet Valley, Pa.
Fall River firm to use cash to prepare a 510k FDA application for its RF tissue repair device.
Two former executives from Johnson & Johnson and Stryker raised $1 million to fund the development of a device that uses radio frequencies to repair torn or frayed cartilage.
NuOrtho Surgical Inc. in Fall River raised the money from private investors and “individuals familiar with the orthopedic industry,” according to a press release.
The funds will be used to file for a 510k premarket notification with the U.S. Food and Drug Administration, ahead of a planned 2010 launch of NuOrtho’s first product.
Reading-based HIT software and service provider expands its Left Coast presence with acquisition of Santa Ana, Calif.-based peer.
Vitalize Consulting Solutions Inc. acquired r3 Health Partners LLC for an undisclosed amount.
The Reading-based healthcare information technology software and service provider said the deal expands its footprint to the West Coast, where r3 has its Santa Ana, Calif. base. Vitalize also has operations in Kennett Square, Pa.
Former r3 managing principal John Dal Poggetto will join Vitalize as a senior vice president.
Carver R&D firm sells anchoring technology to Nitinol Devices & Components of Fremont, Calif.
Phase One Medical LLC sold its anchoring technology line to Nitinol Devices & Components of Fremont, Calif., for an undisclosed amount.
The deal was negotiated by Hatch Medical LLC, a technology brokerage firm, with which Phase One has collaborated in the past.
The anchoring technology is used to secure instruments during minimally invasive cardiovascular and radiology procedures and is one of four product lines the Carver-based company produces.
Burlington stent maker’s FiberHalo catheter measures blood vessels from within the catheter’s balloon.
CorNova Inc. is hoping to take stents to a new level by integrating fiberoptic technology into existing balloon catheter design.
The Burlington medical device manufacturer is developing balloon catheters designed to measure blood vessels from within the balloon during procedures, with an eye toward reducing incidences of stent restenosis (thrombosis), Mass High Tech reported.